BBIO
BridgeBio Pharma Inc
Halal Rating :
Last Price
$33.79
Last updated:
Market Cap
-
7D Change
0.16%
1 Year Change
-11.19%
Company Overview
Industries
Exchange
Next Earnings Date
BridgeBio Pharma Inc is a commercial-stage biopharmaceutical company focused on genetic diseases and cancers. The company develops and delivers medicines for patients with genetic diseases and cancers with clear genetic drivers. Their pipeline includes various drug candidates targeting different genetic diseases and cancers.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $2.73m | $217.54m | - | $23.06m | 0.00% | 10.60% |
| June 30, 2024 | $2.17m | $200.64m | - | $22.94m | 0.00% | 11.43% |
| March 31, 2024 | $211.12m | $260.84m | - | $50.06m | 0.00% | 19.19% |
Company Impact
Help us evaluate BridgeBio Pharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.